Pantoc I.V. (Pantoprazole)

Pantoprazole, the active ingredient in Pantoc I.V., is a proton pump inhibitor presented as a sterile solution for intravenous use. It provides rapid suppression of gastric acid secretion in hospitalized patients with conditions such as gastro‑oesophageal reflux disease, erosive oesophagitis, and stress‑related mucosal bleeding.

GNH USA supplies Pantoc I.V. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Pantoprazole is a proton pump inhibitor used to manage acid‑related disorders in acute care settings.

- Gastro‑oesophageal reflux disease (GERD): rapid reduction of gastric acidity in hospitalized patients. - Erosive oesophagitis: promotes healing of mucosal lesions. - Stress‑related mucosal bleeding (SRMD) in critically ill patients: lowers risk of gastrointestinal bleeding. - Prevention of NSAID‑induced ulcer complications in high‑risk patients: provides prophylactic acid suppression.

Pantoprazole may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: watery stools, usually self‑limiting. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe hypersensitivity reactions: including rash, angioedema, or anaphylaxis. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: rare skin reactions. - Clostridioides difficile infection: possible colitis with prolonged use. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Cardiac arrhythmias: rare electrolyte‑related disturbances. - Anaphylactic shock: immediate medical emergency.

When prescribing Pantoc I.V., clinicians should consider several safety measures.

- Renal function assessment: adjust therapy in severe renal impairment. - Hepatic impairment: use caution and monitor liver function tests. - Prolonged therapy monitoring: watch for hypomagnesemia and related complications. - Known hypersensitivity: avoid in patients with documented allergy to pantoprazole or other PPIs. - Cardiovascular risk: monitor patients with existing cardiac disease for arrhythmias. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Pantoc I.V. can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activity, increasing cardiovascular risk. - Atazanavir: decreased absorption of atazanavir, compromising HIV therapy. - Methotrexate: increased methotrexate toxicity, especially with high‑dose regimens.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer anticoagulation monitoring. - Digoxin: may raise serum digoxin levels, necessitating dosage adjustment. - Phenytoin: potential reduction in phenytoin concentrations, monitor seizure control.